These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30472388)

  • 41. Predicting Mortality in Low-Income Country ICUs: The Rwanda Mortality Probability Model (R-MPM).
    Riviello ED; Kiviri W; Fowler RA; Mueller A; Novack V; Banner-Goodspeed VM; Weinkauf JL; Talmor DS; Twagirumugabe T
    PLoS One; 2016; 11(5):e0155858. PubMed ID: 27196252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of fungal bloodstream infection in intensive care units in the Meizhou region of China: species distribution and resistance and the risk factors for patient mortality.
    Xiao G; Liao W; Zhang Y; Luo X; Zhang C; Li G; Yang Y; Xu Y
    BMC Infect Dis; 2020 Aug; 20(1):599. PubMed ID: 32795259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study.
    Iwashyna TJ; Hodgson CL; Pilcher D; Bailey M; van Lint A; Chavan S; Bellomo R
    Lancet Respir Med; 2016 Jul; 4(7):566-573. PubMed ID: 27155770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Opportunistic fungal infections in the critically ill.
    Shelton BK
    Crit Care Nurs Clin North Am; 2000 Sep; 12(3):323-40. PubMed ID: 11855237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LiFe: a liver injury score to predict outcome in critically ill patients.
    Edmark C; McPhail MJW; Bell M; Whitehouse T; Wendon J; Christopher KB
    Intensive Care Med; 2016 Mar; 42(3):361-369. PubMed ID: 26820880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004920. PubMed ID: 16437504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.
    Wohlfarth P; Agis H; Gualdoni GA; Weber J; Staudinger T; Schellongowski P; Robak O
    J Intensive Care Med; 2019 Sep; 34(9):723-731. PubMed ID: 28631531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluid management in the intensive care unit: bioelectrical impedance vector analysis as a tool to assess hydration status and optimal fluid balance in critically ill patients.
    Basso F; Berdin G; Virzì GM; Mason G; Piccinni P; Day S; Cruz DN; Wjewodzka M; Giuliani A; Brendolan A; Ronco C
    Blood Purif; 2013; 36(3-4):192-9. PubMed ID: 24496190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for fluconazole-resistant invasive candidiasis in intensive care unit patients: An analysis from the China Survey of Candidiasis study.
    Liao X; Qiu H; Li R; Guo F; Liu W; Kang M; Kang Y;
    J Crit Care; 2015 Aug; 30(4):862.e1-5. PubMed ID: 26002430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors predicting prolonged empirical antifungal treatment in critically ill patients.
    Zein M; Parmentier-Decrucq E; Kalaoun A; Bouton O; Wallyn F; Baranzelli A; Elmanser D; Sendid B; Nseir S
    Ann Clin Microbiol Antimicrob; 2014 Mar; 13():11. PubMed ID: 24621182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Critically ill patients readmitted to intensive care units--lessons to learn?
    Metnitz PG; Fieux F; Jordan B; Lang T; Moreno R; Le Gall JR
    Intensive Care Med; 2003 Feb; 29(2):241-8. PubMed ID: 12594586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Investigation regarding the correlation between hydroxyethyl starch administration and acute kidney injury in critically ill patients].
    Wang Z; Zhang M; Wang J; Fang X; Zheng S; Zhang Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 May; 27(5):338-42. PubMed ID: 26003636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of liposomal amphotericin B in critically ill patients: a retrospective, multicenter, clinical study.
    Alvarez-Lerma F; Mariscal F; Quintana E; Rialp G; Diaz-Reganon J; Perez MJ; Alvarez-Sanchez B; Ausin Aoiz I;
    J Chemother; 2009 Jun; 21(3):330-7. PubMed ID: 19567355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fungal sepsis in the ICU: are we doing better? Trends in incidence, diagnosis, and outcome.
    Blot S; Charles PE
    Minerva Anestesiol; 2013 Dec; 79(12):1396-405. PubMed ID: 23719654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections.
    van der Geest PJ; Rijnders BJ; Vonk AG; Groeneveld AB
    Mycoses; 2016 Mar; 59(3):179-85. PubMed ID: 26707572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of liposomal amphotericin B on renal function in critically ill patients with renal function impairment.
    Alvarez-Lerma F; Soriano MC; Rodríguez M; Catalán M; Llorente AM; Vidart N; Garitacelaya M; Maraví E; Fernández E; Alvarado F; López M; Alvarez-Sánchez B; Espinosa J; Quintana E;
    Rev Esp Quimioter; 2012 Sep; 25(3):206-15. PubMed ID: 22987267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Analysis of death risk factors for nosocomial infection patients in an ICU: a retrospective review of 864 patients from 2009 to 2015].
    Wang J; Gao P; Guo S; Liu Y; Shao L; Kang H; Zhang J; Liu S; Gao X; Cui Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):704-8. PubMed ID: 27434560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patients.
    Alvarez-Lerma F; Nicolás-Arfelis JM; Rodríguez-Borregán JC; Díaz-Regañón J; Sa-Borges M; García-López F; Allepuz-Palau A
    J Chemother; 2005 Aug; 17(4):417-27. PubMed ID: 16167522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Diagnostics and therapy for invasive fungal infections in an intensive care unit].
    Koch S; Haefner H; Huenger F; Haase G; Wildberger J; Lemmen SW
    Anaesthesist; 2005 Oct; 54(10):1047-64; quiz 1065-6. PubMed ID: 16211405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.